Trial intelligence / Profile preview

Dexmedetomidine for Delirium After Cardiac Surgery

NCT04127500Unknown

Sponsor
Nanjing First Hospital
Start
Aug 2019
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in delirium (2 arms), sponsored by Nanjing First Hospital. Primary endpoints: Delirium incidence at 1 month and alpha7nAChR level at 7 days. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT04127500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04127500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call